A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity
Raffaella Castoldi(Ludwig-Maximilians-Universität München), Claudio Sustmann(Roche Pharma AG (Germany))
Cited by 68
Related Papers
Generation and characterization of multi-specific antibodies for therapeutic applications in oncology
|Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)|2014|0